IPH2102

Innate Pharma: Phase I Clinical Trial of IPH2102/BMS-986015 in Combination With Ipilimumab Announced
Yahoo
Wed, 12/19/12 - 11:19 am
Innate Pharma S.A.
IPH2102
BMS-986015
ipilimumab
solid tumors